Product Information

PERAMPANEL 8 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $19.3305 per EA under NDC 51672420706. Its NADAC has been published 31 times since Jan 21, 2026.

FDA first approved this application on Nov 25, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERAMPANEL 8 MG TABLET

Perampanel
$19.3305per EA
DEA Schedule CIII

Strength

8 mg/1

NDC

51672420706

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERAMPANEL

Approval Type

Generic (ANDA)

FDA Application

ANDA209538

FDA Approved

11/25/2025

TE Code

AB

On Market Since

11/25/2025

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for PERAMPANEL 8 MG TABLET has been published 31 times since Jan 21, 2026, and over the history we have for it it has declined 40.4%. The table below summarizes its recorded NADAC range and movement.

Current price$19.3305 per EA
All-time high$32.4370 (Mar 11, 2026)
All-time low$18.9290 (Jun 17, 2026)
52-week high$32.4370
52-week low$18.9290
Median price$24.6802
Average price$24.9190
Largest weekly change-19.9% (May 20, 2026)
Weeks tracked31
Tracking sinceJan 21, 2026

Price History

1W

+1.1%

1M

+1.1%

3M

-2.2%

6M

-40.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-40.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PERAMPANEL 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 8 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $19.3305 per EA (NDC 51672420706), effective Aug 19, 2026.

How has the price of PERAMPANEL 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERAMPANEL 8 MG TABLET has declined 40.4%. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.

What are the highest and lowest recorded NADAC prices for PERAMPANEL 8 MG TABLET?

Since Jan 21, 2026, the NADAC for PERAMPANEL 8 MG TABLET has ranged from a low of $18.9290 (Jun 17, 2026) to a high of $32.4370 (Mar 11, 2026), with a median of $24.6802 per EA.

Are there cheaper alternatives to PERAMPANEL 8 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERAMPANEL 8 MG TABLET?

PERAMPANEL 8 MG TABLET (NDC 51672420706) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.